Related references
Note: Only part of the references are listed.Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach
Praveen R. Juvvadi et al.
VIRULENCE (2017)
Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes
Jessica C. Song et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2016)
Whole animal HTS of small molecules for antifungal compounds
Maged Muhammed et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29
Tanvi Shekhar-Guturja et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence
Wenrui Gu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China
Yong Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Aspergillus fumigatus Intrinsic Fluconazole Resistance Is Due to the Naturally Occurring T301I Substitution in Cyp51Ap
Florencia Leonardelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans
Yuan-Hua Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system
Maryam Moazeni et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Janaina de Cassia Orlandi Sardi et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Strategies in the discovery of novel antifungal scaffolds
Na Liu et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Evolutionary history of the chitin synthases of eukaryotes
Alexey A. Morozov et al.
GLYCOBIOLOGY (2016)
Synergy and antagonism between iron chelators and antifungal drugs in Cryptococcus
Yu-Wen Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasiliensis and Paracoccidioides lutzii in a Galleria mellonella model
Junya de Lacorte Singulani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation
Fernanda Sangalli-Leite et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
Aline Raquel Voltan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Pathogenicity of Candida albicans isolates from bloodstream and mucosal candidiasis assessed in mice and Galleria mellonella
M. Frenkel et al.
JOURNAL DE MYCOLOGIE MEDICALE (2016)
Compensatory expression of multidrug-resistance genes encoding ABC transporters in dermatophytes
Maira Pompeu Martins et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Analysis of Sporothrix schenckii sensu stricto and Sporothrix brasiliensis virulence in Galleria mellonella
Diana M. Clavijo-Giraldo et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2016)
Azole Resistance in Dermatophytes Prevalence and Mechanism of Action
Mahmoud Ghannoum
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (2016)
Amphotericin B-conjugated biogenic silver nanoparticles as an innovative strategy for fungal infections
Aftab Ahmad et al.
MICROBIAL PATHOGENESIS (2016)
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Sarah Santos Goncalves et al.
MYCOSES (2016)
Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics
Katarzyna Niemirowicz et al.
Nanomedicine-Nanotechnology Biology and Medicine (2016)
Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis
Visesato Mor et al.
PLOS ONE (2016)
Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans
Shuyuan Liu et al.
PLOS ONE (2016)
Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates
Maria E. Bosco-Borgeat et al.
REVISTA ARGENTINA DE MICROBIOLOGIA (2016)
A complex game of hide and seek: the search for new antifungals
Huy X. Ngo et al.
MEDCHEMCOMM (2016)
The Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility
Jinxing Song et al.
MBIO (2016)
Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans
Wei Huang et al.
MBIO (2016)
Phenotypic switching of Candida tropicalis is associated with cell damage in epithelial cells and virulence in Galleria mellonella model
Alane T-P. Moralez et al.
VIRULENCE (2016)
Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans
Elaheh Movahed et al.
Frontiers in Microbiology (2016)
Virulence of Cryptococcus sp Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative Model
Tatiane Benaducci et al.
FRONTIERS IN MICROBIOLOGY (2016)
Newer patents in antimycotic therapy
Sukhbir K. Shahid
PHARMACEUTICAL PATENT ANALYST (2016)
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Dominique Sanglard
FRONTIERS IN MEDICINE (2016)
Combination Antifungal Therapy for Invasive Aspergillosis A Randomized Trial
Kieren A. Marr et al.
ANNALS OF INTERNAL MEDICINE (2015)
Blocking Hsp70 Enhances the Efficiency of Amphotericin B Treatment against Resistant Aspergillus terreus Strains
Michael Blatzer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae
Ana Carolina R. Souza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
Li Zhang et al.
BMC INFECTIOUS DISEASES (2015)
Echinocandin Resistance in Candida
David S. Perlin
CLINICAL INFECTIOUS DISEASES (2015)
Recent Advances in Nanoparticle Carriers for Coordination Complexes
Mariana Rillo Sato et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Azole antifungals: 35 years of invasive fungal infection management
David Allen et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies
Issam I. Raad et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans
Luiz R. Basso et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
New insights on the development of fungal vaccines: from immunity to recent challenges
Natasha P. Medici et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Zebrafish as tools for drug discovery
Calum A. MacRae et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Live Imaging of Host-Parasite Interactions in a Zebrafish Infection Model Reveals Cryptococcal Determinants of Virulence and Central Nervous System Invasion
Jennifer L. Tenor et al.
MBIO (2015)
Comparison of virulence between Paracoccidioides brasiliensis and Paracoccidioides lutzii using Galleria mellonella as a host model
Liliana Scorzoni et al.
VIRULENCE (2015)
In vitro Paracoccidioides brasiliensis biofilm and gene expression of adhesins and hydrolytic enzymes
Janaina de Cassia Orlandi Sardi et al.
VIRULENCE (2015)
Vaccines in the treatment of invasive candidiasis
Xiao-juan Wang et al.
VIRULENCE (2015)
Adaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibility
Kerstin Kaerger et al.
VIRULENCE (2015)
Heat Shock Protein 90 (Hsp90) as a Molecular Target for the Development of Novel Drugs Against the Dermatophyte Trichophyton rubrum
TiagoR. Jacob et al.
FRONTIERS IN MICROBIOLOGY (2015)
Role of Sterylglucosidase 1 (SgI1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development
Antonella Rella et al.
FRONTIERS IN MICROBIOLOGY (2015)
Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a US Surveillance System
Nina T. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A Multi-Host Approach for the Systematic Analysis of Virulence Factors in Cryptococcus neoformans
Athanasios Desalermos et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance
Mikhail V. Keniya et al.
PLOS ONE (2015)
Zebrafish Egg Infection Model for Studying Candida albicans Adhesion Factors
Yin-Zhi Chen et al.
PLOS ONE (2015)
Mechanisms of Antifungal Drug Resistance
Leah E. Cowen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Combination Antifungal Therapy: When, Where, and Why
Elizabeth S. Belanger et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2015)
The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug
Ana Cecilia Mesa-Arango et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Synergistic Activity of the Tyrocidines, Antimicrobial Cyclodecapeptides from Bacillus aneurinolyticus, with Amphotericin B and Caspofungin against Candida albicans Biofilms
Anscha Mari Troskie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vivo and In Vitro Acquisition of Resistance to Voriconazole by Candida krusei
Elisabete Ricardo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro Combination of Isavuconazole with Micafungin or Amphotericin B Deoxycholate against Medically Important Molds
Aspasia Katragkou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms
C. B. Costa-Orlandi et al.
BIOFOULING (2014)
Assessment of in vivo antimicrobial activity of the carbene silver(I) acetate derivative SBC3 using Galleria mellonella larvae
Niall Browne et al.
BIOMETALS (2014)
Update on antifungal resistance in Aspergillus and Candida
M. C. Arendrup
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Anti-Trichophyton Activity of Protocatechuates and Their Synergism with Fluconazole
Luciana Arantes Soares et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Inhibitory effect of verapamil on Candida albicans hyphal development, adhesion and gastrointestinal colonization
Qilin Yu et al.
FEMS YEAST RESEARCH (2014)
Elucidating drug resistance in human fungal pathogens
Jinglin Lucy Xie et al.
FUTURE MICROBIOLOGY (2014)
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms
Anuradha Chowdhary et al.
FUTURE MICROBIOLOGY (2014)
Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania
Anuradha Chowdhary et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata
Cau D. Pham et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Amphotericin forms an extramembranous and fungicidal sterol sponge
Thomas M. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
An opportunistic human pathogen on the fly: Strains of Aspergillus flavus vary in virulence in Drosophila melanogaster
Luis A. Ramirez-Camejo et al.
MEDICAL MYCOLOGY (2014)
ASDCD: Antifungal Synergistic Drug Combination Database
Xing Chen et al.
PLOS ONE (2014)
The Triphenylethylenes, a Novel Class of Antifungals
Audrey R. Odom
MBIO (2014)
Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo
Arielle Butts et al.
MBIO (2014)
Expanding the use of alternative models to investigate novel aspects of immunity to microbial pathogens
Nuria Trevijano-Contador et al.
VIRULENCE (2014)
Fungal Vaccines and Immunotherapeutics
Evelyn Santos et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Efflux pump proteins in ant fungal resistance
Rajendra Prasad et al.
FRONTIERS IN PHARMACOLOGY (2014)
Mechanism of Action of Efinaconazole, a Novel Triazole Antifungal Agent
Yoshiyuki Tatsumi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Amphotericin B- and Voriconazole-Echinocandin Combinations against Aspergillus spp.: Effect of Serum on Inhibitory and Fungicidal Interactions
Antigoni Elefanti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Properties and mechanisms of action of naturally occurring antifungal peptides
Nicole L. van der Weerden et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis
Francesca Bugli et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus
G. Blum et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Azole resistance in Aspergillus fumigatus: a growing public health concern
Edith Vermeulen et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
Inhalable highly concentrated itraconazole nanosuspension for the treatment of bronchopulmonary aspergillosis
Chris Rundfeldt et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection
Wanessa C. M. A. de Melo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers
Yuan Gao et al.
FEMS YEAST RESEARCH (2013)
Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans
Ming-Jie Xiang et al.
FEMS YEAST RESEARCH (2013)
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries
Livio Pagano et al.
HAEMATOLOGICA (2013)
Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
Cen Jiang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii
Gabriella Freitas Ferreira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Tacrolimus Enhances the Potency of Posaconazole Against Rhizopus oryzae In Vitro and in an Experimental Model of Mucormycosis
Russell E. Lewis et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran
Hamid Badali et al.
MYCOSES (2013)
Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
Liliana Scorzoni et al.
PLOS ONE (2013)
Exopolymer Diversity and the Role of Levan in Bacillus subtilis Biofilms
Iztok Dogsa et al.
PLOS ONE (2013)
Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development
Malgorzata Bondaryk et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2013)
Galleria mellonella as a model host to study Paracoccidioides lutzii and Histoplasma capsulatum
Luciana Thomaz et al.
VIRULENCE (2013)
Calcineurin Governs Thermotolerance and Virulence of Cryptococcus gattii
Ying-Lien Chen et al.
G3-GENES GENOMES GENETICS (2013)
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Benjamin Matteson Vincent et al.
PLOS BIOLOGY (2013)
Innovative Strategies to Overcome Biofilm Resistance
Aleksandra Taraszkiewicz et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata
Salma Abbes et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
An oral vaccine against candidiasis generated by a yeast molecular display system
Seiji Shibasaki et al.
PATHOGENS AND DISEASE (2013)
Azole-Resistant Aspergillus fumigatus, Iran
Seyedmojtaba Seyedmousavi et al.
EMERGING INFECTIOUS DISEASES (2013)
Yeast ATP-Binding Cassette Transporters Conferring Multidrug Resistance
Rajendra Prasad et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 66 (2012)
Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole
Edward Sionov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Azole Resistance by Loss of Function of the Sterol Δ5,6-Desaturase Gene (ERG3) in Candida albicans Does Not Necessarily Decrease Virulence
L. A. Vale-Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface
N. S. Pitangui et al.
BIOFOULING (2012)
In vitro activities of antifungal agents alone and in combination against fluconazole-susceptible and -resistant strains of Candida dubliniensis
Liliane Alves Scheid et al.
Brazilian Journal of Infectious Diseases (2012)
A Flucytosine-Responsive Mbp1/Swi4-Like Protein, Mbs1, Plays Pleiotropic Roles in Antifungal Drug Resistance, Stress Response, and Virulence of Cryptococcus neoformans
Min-Hee Song et al.
EUKARYOTIC CELL (2012)
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence
Florent Morio et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Fungal cell wall vaccines: an update
John E. Edwards
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India
Anuradha Chowdhary et al.
PLOS ONE (2012)
Zebrafish embryos as an alternative to animal experiments-A commentary on the definition of the onset of protected life stages in animal welfare regulations
Uwe Straehle et al.
REPRODUCTIVE TOXICOLOGY (2012)
Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli
Dorota Wojnicz et al.
UROLOGICAL RESEARCH (2012)
Biofilm formation of Malassezia pachydermatis from dogs
Luciana A. Figueredo et al.
VETERINARY MICROBIOLOGY (2012)
Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis
Glauce M. G. Rittner et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
A Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Heather T. Taff et al.
PLOS PATHOGENS (2012)
Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models
Camaron R. Hole et al.
FRONTIERS IN MICROBIOLOGY (2012)
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges
Anna Vecchiarelli et al.
FRONTIERS IN MICROBIOLOGY (2012)
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Ana C. Mesa-Arango et al.
Frontiers in Microbiology (2012)
In Vitro Interaction between Fluconazole and Triclosan against Clinical Isolates of Fluconazole-Resistant Candida albicans Determined by Different Methods
Lu Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene
Shawn R. Lockhart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Advances in synthetic approach to and antifungal activity of triazoles
Kumari Shalini et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2011)
Protective Immunity against Experimental Pulmonary Cryptococcosis in T Cell-Depleted Mice
Karen L. Wozniak et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
New Lead Structures in Antifungal Drug Discovery
Chunquan Sheng et al.
CURRENT MEDICINAL CHEMISTRY (2011)
C. elegans: model host and tool for antimicrobial drug discovery
Jonathan J. Ewbank et al.
DISEASE MODELS & MECHANISMS (2011)
Live Imaging of Disseminated Candidiasis in Zebrafish Reveals Role of Phagocyte Oxidase in Limiting Filamentous Growth
Kimberly M. Brothers et al.
EUKARYOTIC CELL (2011)
Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host
Jeffrey J. Coleman et al.
FUNGAL BIOLOGY (2011)
Immunization with Apoptotic Phagocytes Containing Histoplasma capsulatum Activates Functional CD8+ T Cells To Protect against Histoplasmosis
Shih-Hung Hsieh et al.
INFECTION AND IMMUNITY (2011)
Combined use of Paracoccidioides brasiliensis recombinant rPb27 and rPb40 antigens in an enzyme-linked immunosorbent assay for immunodiagnosis of paracoccidioidomycosis
V. C. Fernandes et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Molecular Mechanisms of Resistance to 5-Fluorocytosine in Laboratory Mutants of Candida glabrata
Patrick Vandeputte et al.
MYCOPATHOLOGIA (2011)
Candida parapsilosis complex water isolates from a haemodialysis unit: biofilm production and in vitro evaluation of the use of clinical antifungals
Regina Helena Pires et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2011)
Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst
Fernanda Sangalli-Leite et al.
MICROBES AND INFECTION (2011)
Biofilm formation by zygomycetes: quantification, structure and matrix composition
Rachna Singh et al.
MICROBIOLOGY-SGM (2011)
Pathogenesis of Candida albicans Infections in the Alternative Chorio-Allantoic Membrane Chicken Embryo Model Resembles Systemic Murine Infections
Ilse D. Jacobsen et al.
PLOS ONE (2011)
Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
Claire M. Martel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
Florent Morio et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Embryonated Eggs as an Alternative Infection Model To Investigate Aspergillus fumigatus Virulence
Ilse D. Jacobsen et al.
INFECTION AND IMMUNITY (2010)
Zebrafish as a Model Host for Candida albicans Infection
Chun-Cheih Chao et al.
INFECTION AND IMMUNITY (2010)
Genetic Basis of Candida Biofilm Resistance Due to Drug-Sequestering Matrix Glucan
Jeniel E. Nett et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Presence of Extracellular DNA in the Candida albicans Biofilm Matrix and its Contribution to Biofilms
Margarida Martins et al.
MYCOPATHOLOGIA (2010)
Role of filamentation in Galleria mellonella killing by Candida albicans
Beth Burgwyn Fuchs et al.
MICROBES AND INFECTION (2010)
Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms
Heleen Nailis et al.
RESEARCH IN MICROBIOLOGY (2010)
Role of the heat shock transcription factor, Hsf1, in a major fungal pathogen that is obligately associated with warm-blooded animals
Alistair J. P. Brown et al.
VIRULENCE (2010)
Methods for using Galleria mellonella as a model host to study fungal pathogenesis
Beth Burgwyn Fuchs et al.
VIRULENCE (2010)
Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
Priya Uppuluri et al.
PLOS PATHOGENS (2010)
Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes
Edward Sionov et al.
PLOS PATHOGENS (2010)
Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei
Erwin Lamping et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Role for Fks1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae
Santosh K. Katiyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Efflux-Mediated Antifungal Drug Resistance
Richard D. Cannon et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Our Current Understanding of Fungal Biofilms
Gordon Ramage et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2009)
Amphotericin B and Its New Derivatives - Mode of Action
M. Baginski et al.
CURRENT DRUG METABOLISM (2009)
Novel Approaches to Control Biofilm Infections
Andreia Bergamo Estrela et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Candida albicans Hyphal Formation and Virulence Assessed Using a Caenorhabditis elegans Infection Model
Read Pukkila-Worley et al.
EUKARYOTIC CELL (2009)
Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation
Dominique Sanglard et al.
FEMS YEAST RESEARCH (2009)
Time Course Global Gene Expression Analysis of an In Vivo Candida Biofilm
Jeniel E. Nett et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole
Silvia Borecka-Melkusova et al.
MYCOSES (2009)
Histoplasma capsulatum and Caenorhabditis elegans: a simple nematode model for an innate immune response to fungal infection
Clayton H. Johnson et al.
MEDICAL MYCOLOGY (2009)
The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?
Eilidh Mowat et al.
MEDICAL MYCOLOGY (2009)
Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay
Ikechukwu Okoli et al.
PLOS ONE (2009)
Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure
Susan J. Howard et al.
EMERGING INFECTIOUS DISEASES (2009)
Mutations in the fks1 gene in Candida albicans, C-tropicalis, and C-krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing
Marie Desnos-Ollivier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A chemical genomic screen in Saccharomyces cerevisiae reveals a role for diphthamidation of translation elongation factor 2 in inhibition of protein synthesis by sordarin
Javier Botet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
MFS transportome of the human pathogenic yeast Candida albicans
Manisha Gaur et al.
BMC GENOMICS (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
A gain-of-function mutation in the transcription factor Upc2p causes Upregulation of ergosterol biosynthesis genes and increased Fluconazole resistance in a clinical Candida albicans isolate
Nico Dunkel et al.
EUKARYOTIC CELL (2008)
Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity
Armel Plaine et al.
FUNGAL GENETICS AND BIOLOGY (2008)
Anti-biofilm properties of chitosan-coated surfaces
Ross P. Carlson et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2008)
Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome
Bradley J. Atkinson et al.
MEDICAL MYCOLOGY (2008)
Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis
Alexandre F. Marques et al.
MICROBES AND INFECTION (2008)
Candidemia in a tertiary hospital in northeastern Brazil
Sylvia Lemos Hinrichsen et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2008)
A seed and feed model for the formation of Candida albicans biofilms under flow conditions using an improved modified Robbins device
Gordon Ramage et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2008)
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster
Gregory A. Lamaris et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A Ser678Pro substitution in fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus
Eleusa Maria F. Rocha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates
Alix Coste et al.
EUKARYOTIC CELL (2007)
Role for cell density in antifungal drug resistance in Candida albicans biofilms
Palani Perumal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light
Luis R. Martinez et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Identification of y118 amino acid residue in Candida albicans sterol 14α-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues
Shuang-Hong Chen et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
Analysis of Trichophyton rubrum gene expression in response to cytotoxic drugs
Fernanda G. Paiao et al.
FEMS MICROBIOLOGY LETTERS (2007)
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole
Shaoji Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Multiple-triazole-resistant aspergillosis
Paul E. Verweij et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs:: results of a multicenter study conducted in Sao Paulo, Brazil, 1995-2003
Daniel Archimedes da Matta et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Antifungal chemical compounds identified using a C-elegans pathogenicity assay
Julia Breger et al.
PLOS PATHOGENS (2007)
Biofilm development by clinical isolates of Malassezia pachydermatis
Francesca T. Cannizzo et al.
MEDICAL MYCOLOGY (2007)
Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum
Lu Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Molecular mechanism of flucytosine resistance in Candida lusitaniae: Contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance
Nicolas Papon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Joshua Perlroth et al.
MEDICAL MYCOLOGY (2007)
Persister cells, dormancy and infectious disease
Kim Lewis
NATURE REVIEWS MICROBIOLOGY (2007)
Candida albicans biofilms produce antifungal-tolerant persister cells
Michael D. LaFleur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A small Subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and β-1,6-glucan pathway genes
Prasanna D. Khot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development
Mohammed A. S. Alem et al.
EUKARYOTIC CELL (2006)
Biofilm formation by the emerging fungal pathogen Trichosporon asahii:: Development, architecture, and antifungal resistance
Giovanni Di Bonaventura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Fluconazole resistance mechanisms in Candida krusei:: The contribution of efflux-pumps
J. Guinea et al.
MEDICAL MYCOLOGY (2006)
The structure and synthesis of the fungal cell wall
Shaun M. Bowman et al.
BIOESSAYS (2006)
Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis
A. F. Marques et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum
Ana Lucia Fachin et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Aneuploidy and isochromosome formation in drug-resistant Candida albicans
Anna Selmecki et al.
SCIENCE (2006)
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus
William J. Steinbach et al.
EUKARYOTIC CELL (2006)
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole
LJ Wheat et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Antifungal drug resistance: limited data, dramatic impact?
Thomas R. Rogers
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans
D Hiller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species
G Chamilos et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Molecular cloning and characterization of a novel ABC transporter gene in the human pathogen Trichophyton rubrum
ER Cervelatti et al.
MEDICAL MYCOLOGY (2006)
Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi
CP Semighini et al.
MOLECULAR MICROBIOLOGY (2006)
Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans
M Sanguinetti et al.
INFECTION AND IMMUNITY (2006)
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
Sergey V. Balashov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Fungal heat-shock proteins in human disease
JR Burnie et al.
FEMS MICROBIOLOGY REVIEWS (2006)
Optimizing efficacy of amphotericin B through nanomodification
Suresh P. Vyas et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2006)
Current advances in antifungal targets and drug development
S Sundriyal et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms
J Chandra et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Mechanisms of azole resistance in a clinical isolate of Candida tropicalis
P Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inactivation of sterol Δ5,6-desaturase attenuates virulence in Candida albicans
AS Chau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Cryptococcus neoformans resistance to echinocandins:: (1,3)β-glucan synthase activity is sensitive to echinocandins
MA Maligie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth
B Enjalbert et al.
EUKARYOTIC CELL (2005)
cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol
YY Cao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance
M Sanguinetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Comparison of protective effect of protein and DNA Vaccines hsp90 in murine model of systemic candidiasis
M Raska et al.
FOLIA MICROBIOLOGICA (2005)
Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response
Y Apidianakis et al.
EUKARYOTIC CELL (2004)
History of the development of azole derivatives
JA Maertens
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Combination antifungal therapy
MD Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil
GH Goldman et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Molecular mechanisms of primary resistance to flucytosine in Candida albicans
WW Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to Azoles
AS Chau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis
JE Bennett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection
SP Saville et al.
EUKARYOTIC CELL (2003)
Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn:: case report and review of the literature
A Favel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Molecular mechanisms of itraconazole resistance in Candida dubliniensis
E Pinjon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mechanism of fluconazole resistance in Candida albicans biofilms:: Phase-specific role of efflux pumps and membrane sterols
PK Mukherjee et al.
INFECTION AND IMMUNITY (2003)
Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90
RC Matthews et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Calcineurin is essential for Candida albicans survival in serum and virulence
JR Blankenship et al.
EUKARYOTIC CELL (2003)
Antifungal agents: mechanisms of action
FC Odds et al.
TRENDS IN MICROBIOLOGY (2003)
Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method
C Lass-Flörl et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus
TM Diaz-Guerra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome p450 14α-demethylase
PA Mann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole
B Posteraro et al.
MOLECULAR MICROBIOLOGY (2003)
Molecular mechanism of terbinafine resistance in Saccharomyces cerevisiae
R Leber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate
L Rodero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants
S Bozza et al.
MICROBES AND INFECTION (2002)
Vaccination of corticosteroid Immunosuppressed mice against invasive pulmonary aspergillosis
JI Ito et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate
JW Slaven et al.
FUNGAL GENETICS AND BIOLOGY (2002)
Resistance of human fungal pathogens to antifungal drugs
D Sanglard
CURRENT OPINION IN MICROBIOLOGY (2002)
Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis
WR Kirkpatrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The genetic basis of fluconazole resistance development in Candida albicans
J Morschhäuser
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Resistance mechanisms in clinical isolates of Candida albicans
TC White et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
G Ramage et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins
DM Kuhn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer
SW Redding et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site
N Jia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Biofilm on ventriculoperitoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis
LE Davis et al.
EMERGING INFECTIOUS DISEASES (2002)
Resistance of Candida species to antifungal agents:: molecular mechanisms and clinical consequences
D Sanglard et al.
LANCET INFECTIOUS DISEASES (2002)
Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo
SF Gee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
MFAME, N-methyl-N-D-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity:: relationship between self-association and effects on red blood cells
J Szlinder-Richert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2001)
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
G Ramage et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol
JM Hornby et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Riddle of biofilm resistance
K Lewis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro
J Chandra et al.
JOURNAL OF DENTAL RESEARCH (2001)
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis
A Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Candida lusitaniae:: A cause of breakthrough fungemia in cancer patients
A Minari et al.
CLINICAL INFECTIOUS DISEASES (2001)
Biofilm exopolysaccharides: a strong and sticky framework
IW Sutherland
MICROBIOLOGY-UK (2001)
Interactions between triazoles and amphotericin B against Cryptococcus neoformans
F Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents
GS Baillie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
T cell vaccination in mice with invasive pulmonary aspergillosis
E Cenci et al.
JOURNAL OF IMMUNOLOGY (2000)
Novel approaches in the rational design of antifungal agents of low toxicity
E Borowski
FARMACO (2000)
The R467K amino acid substitution in Candida albicans sterol 14 alpha-demethylase causes drug resistance through reduced affinity
DC Lamb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
